We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SGE:LSESage Group plc Analysis

Data as of 2026-06-12 - not real-time

£807.60

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The Sage Group (SGE) is trading at £8.08 (807.6p), barely above its 20‑day support of £7.99 and well below the 200‑day SMA of £9.82, suggesting limited upside in the immediate term. Technicals are bearish – the MACD line sits ‑12.3 below the signal at ‑5.44, the histogram is negative, and the 14‑day RSI is only 37.9, indicating modest oversold pressure. Volume has been decreasing, reinforcing the short‑term weakness, yet the stock’s beta of 0.26 points to low market‑wide volatility, though its 30‑day price swing of 39% remains high.
Fundamentally, Sage delivered an "excellent first half" with double‑digit revenue growth (~11%), margin expansion to a 22.3% operating margin, and a 16% EPS increase, driven by AI‑enhanced cloud offerings. The DCF‑derived fair value of £12.13 implies roughly 35% upside from current levels, while a 2.79% dividend yield and a 55% payout ratio appear sustainable given strong operating cash flow and free cash flow generation. The company’s low debt‑to‑equity ratio is distorted by a high absolute debt load, but the ROE of 75% reflects efficient capital use. Overall, Sage blends growth momentum with attractive valuation and dividend characteristics, making it a compelling medium‑term prospect despite near‑term technical headwinds.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and RSI indicating limited near‑term upside
  • Price hovering just above key support level
  • Decreasing volume suggesting reduced short‑term buying interest

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~35% and current price well below fair value
  • Strong H1 revenue and margin expansion driven by AI‑enabled cloud products
  • Sustainable dividend yield with solid cash flow generation

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term growth narrative anchored in recurring revenue and AI integration
  • High ROE and consistent free cash flow supporting dividend stability
  • Undervaluation relative to industry peers and attractive long‑term upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth9.70%
Profit Margin14.62%
P/E Ratio20.2
ROE75.56%
ROA9.53%
Debt/Equity919.09
P/B Ratio33.9
Op. Cash Flow£530.0M
Free Cash Flow£632.2M
Industry P/E36.5

Technical Analysis

TrendBearish
RSI37.9
Support£799.20
Resistance£921.00
MA 20£864.85
MA 50£871.62
MA 200£982.05
MACDBearish
VolumeDecreasing
Fear & Greed Index86.71

Valuation

Fair Value£1,212.66
Target Price£1,092.32
Upside/Downside35.25%
GradeUndervalued
TypeBlend
Dividend Yield2.79%

Risk Assessment

Beta0.26
Volatility39.27%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.